IndusLaw Deal Report -Blue Tokai funding
Our Firm advised and represented Muhavra Enterprises Private Limited (“Blue Tokai”) in relation to Series C funding of USD 30 million from A91 Emerging Fund II LLP (“A91”) and other existing investors. [1]
IndusLaw Deal report (Sarvagram)
Our Firm advised and represented SarvaGram and Elevar in relation to investment of USD 35 million into SarvaGram by Temasek, TVS Capital Funds, and existing investors, Elevar and Elevation Capital [1].
IndusLaw Deal Report – Takahata -Shriram
Takahata Precision Co. Ltd. and Takahata Precision Pte. Ltd. (“Takahata Group”) have executed a share purchase agreement and other definitive documents with SPR Engenious Limited, a wholly owned subsidiary of Shriram Pistons & Rings Limited (“SPRL”), in relation to a divestment of 75% of their shareholding in Takahata Precision India Private Limited (“Takahata India”) [1].
IndusLaw Deal Report – Syngene Block deal
Our Firm has advised Spark Institutional Equities and Avendus Capital in relation to the recently concluded stake sale of Syngene International by its promoter Biocon Limited through a block deal on the screen based trading platform of stock exchanges. Syngene is an integrated research, development and manufacturing organisation providing scientific services – from early discovery …
Continue reading “IndusLaw Deal Report – Syngene Block deal”
IndusLaw Deal Report – ReNew
Firm advised and represented ReNew Power Private Limited (“Renew India”) in relation to acquisition of shares in 3E NV by Renew Power International Limited (a UK based affiliate of Renew India) from the shareholders of 3E NV in two tranches.
IndusLaw Deal Report – Renee Cosmetics Series C
Our Firm advised and represented Evolvence in relation to its Series C investment into Renee Cosmetics Private Limited along with other investors – Edelweiss Discovery Fund, Equanimity Ventures Trust and 9Unicorns Accelerator [1]. This also leads to creating a USD 100 million valuation for the brand in a little over two years of operations.
IndusLaw Deal Report – PhonePe Funding USD 350 million
Our firm advised and represented PhonePe in relation to its fund raise of USD 350 million from General Atlantic, a leading global growth equity firm, at a pre-money valuation of USD 12 billion[1]. The General Atlantic investment marks the first tranche of an up to USD 1 billion total fundraise that PhonePe commenced in January …
Continue reading “IndusLaw Deal Report – PhonePe Funding USD 350 million”
HEUSSEN: Among the best in the Handelsblatt “Germany’s Best Lawyers 2022/2023”
HEUSSEN, a full-service commercial law firm with offices in Munich, Stuttgart, Berlin and Frankfurt, was able to further strengthen its position this year and is represented by lawyers in all major practice areas. Partner Tobias Scholl from the Stuttgart office was named “Lawyer of the Year in Baden-Württemberg” for insurance law, and Dr Hermann Waldhauser …
Continue reading “HEUSSEN: Among the best in the Handelsblatt “Germany’s Best Lawyers 2022/2023””
HEUSSEN: Unter den Besten im Handelsblatt „Deutschlands Beste Anwälte 2022/2023“
Auch in diesem Jahr hat das Handelsblatt in Zusammenarbeit mit dem US-Verlag „Best Lawyers“ die renommiertesten deutschen Juristen aus verschiedenen Rechtsgebieten ermittelt.
HEUSSEN again among the top law firms for public procurement law 2022/2023”
WirtschaftsWoche (WiWo) has once again searched for the top law firms in Germany for public procurement law. And for the fifth time, partner Uwe Carsten Völlink and HEUSSEN’s public procurement law practice are among the best. For the list of the top law firms and lawyers for public procurement law 2022, the Handelsblatt Research Institute …
Continue reading “HEUSSEN again among the top law firms for public procurement law 2022/2023””